109 related articles for article (PubMed ID: 11260082)
1. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.
Küpper M; Joos S; von Bonin F; Daus H; Pfreundschuh M; Lichter P; Trümper L
Br J Haematol; 2001 Mar; 112(3):768-75. PubMed ID: 11260082
[TBL] [Abstract][Full Text] [Related]
2. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
Elenitoba-Johnson KS; Medeiros LJ; Khorsand J; King TC
Am J Clin Pathol; 1996 Dec; 106(6):728-38. PubMed ID: 8980348
[TBL] [Abstract][Full Text] [Related]
3. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease.
Chilosi M; Doglioni C; Menestrina F; Montagna L; Rigo A; Lestani M; Barbareschi M; Scarpa A; Mariuzzi GM; Pizzolo G
Blood; 1994 Dec; 84(12):4295-300. PubMed ID: 7994045
[TBL] [Abstract][Full Text] [Related]
5. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
6. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
7. The mummified Hodgkin cell: cell death in Hodgkin's disease.
Lorenzen J; Thiele J; Fischer R
J Pathol; 1997 Jul; 182(3):288-98. PubMed ID: 9349231
[TBL] [Abstract][Full Text] [Related]
8. Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations.
Trümper LH; Brady G; Bagg A; Gray D; Loke SL; Griesser H; Wagman R; Braziel R; Gascoyne RD; Vicini S
Blood; 1993 Jun; 81(11):3097-115. PubMed ID: 8499644
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in Hodgkin's disease.
Chen WG; Chen YY; Kamel OW; Koo CH; Weiss LM
Lab Invest; 1996 Oct; 75(4):519-27. PubMed ID: 8874383
[TBL] [Abstract][Full Text] [Related]
11. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.
Ohshima K; Haraoka S; Fujiki T; Yoshioka S; Suzumiya J; Kanda M; Kikuchi M
Pathol Int; 1999 Jun; 49(6):506-12. PubMed ID: 10469393
[TBL] [Abstract][Full Text] [Related]
12. N-ras genes are not mutated in Hodgkin and Reed-Sternberg cells: results from single cell polymerase chain-reaction examinations.
Trümper L; Pfreundschuh M; Jacobs G; von Bonin F; Loftin U; Möller P; Daus H
Leukemia; 1996 Apr; 10(4):727-30. PubMed ID: 8618454
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
14. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
[TBL] [Abstract][Full Text] [Related]
15. p16INK4A is regularly expressed in Hodgkin's disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virus.
Guenova M; Rassidakis GZ; Gorgoulis VG; Angelopoulou MK; Siakantaris MR; Kanavaros P; Pangalis GA; Kittas C
Mod Pathol; 1999 Nov; 12(11):1062-71. PubMed ID: 10574604
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
[TBL] [Abstract][Full Text] [Related]
17. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
18. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease.
Xerri L; Parc P; Bouabdallah R; Camerlo J; Hassoun J
J Pathol; 1995 Feb; 175(2):189-94. PubMed ID: 7738714
[TBL] [Abstract][Full Text] [Related]
19. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease.
Louie DC; Kant JA; Brooks JJ; Reed JC
Am J Pathol; 1991 Dec; 139(6):1231-7. PubMed ID: 1750500
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances.
Franke S; Wlodarska I; Maes B; Vandenberghe P; Delabie J; Hagemeijer A; De Wolf-Peeters C
Blood; 2001 Mar; 97(6):1845-53. PubMed ID: 11238128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]